Finnegan's Take

Archives for Innovation and Growth

Amid resignations, political spats and question marks over its budget, there’s a new broom at the EU’s powerful medicines authority Pity Guido Rasi. Not for his €200 salary, the generous perks or the swanky Canary Wharf offices, but for the unenviable task of turning around the ailing European Medicines Agency. He takes the helm at… » read more

Posted by Gary Finnegan

EU leaders seem to have just discovered the EIB but the truth is the bank has grown increasingly active since the crisis broke In the sleepy Luxembourg headquarters of the European Investment Bank they are unsure how to handle their 15 minutes of fame. Suddenly everyone from François Hollande and Angela Merkel to David Cameron… » read more

Posted by Gary Finnegan

The draft EU budget is a win for Geoghegan-Quinn but it won’t make her popular at home. The EU’s budget has been the subject of much wrangling of late, with the usual tug-of-war between interest groups from industry, agriculture and the rest. Ireland’s European Commissioner Máire Geoghegan-Quinn, who is responsible for research, innovation and science,… » read more

Posted by Gary Finnegan

Fears that Greece could default on its debt tops the EU agenda because it puts the balance sheets of a dozen German and French banks in peril. But Greece has already defaulted on its debts to companies. What is default? EU leaders have been trying to find a way around the fact that Greece cannot… » read more

Posted by Gary Finnegan

The EU’s clinical trials directive has been a catastrophe but Brussels is keen to make amends “Arguably the most criticised piece of legislation” the EU has ever produced on medicines. That’s how the European Commission describes its own law on clinical trials, drafted a decade ago in an effort to streamline medical research in Europe.… » read more

Posted by Gary Finnegan

Irish health services have been slow to embrace technology and need to mobilise its staff to catch up Electronic patient records, access to specialist services from home, and more efficient use of scarce resources are just some of the much-vaunted benefits touted by advocates of e-health. But while technology has transformed most industries and public… » read more

Posted by Gary Finnegan

Some businesspeople want government to leave them alone; others want a bailout and shelter from the storm. They can’t have both. It’s (still) SME Week and I’ve met a lot of entrepreneurs in the last couple of days. They are interesting people: dreamers, risk-takers and chancers in varying measure. But I note a philosophical divide… » read more

Posted by Gary Finnegan

“European Research Council in full flight,” screams the July issue of the Europe4Researchers newsletter published by the European Commission, which landed in my inbox on this afternoon. The article boasts that the ERC has “developed into a well-functioning research funding body”. Great news, if it were true. Yesterday a panel of experts – assembled by… » read more

Posted by Gary Finnegan

When words like “subprime” and “credit crunch” entered the public lexicon in 2007, commentators said it would pass within a few months. Once banks published their annual reports, they said, we’d know who had toxic assets on their balance sheets and confidence would return to the markets. That was two years ago. Now, as the… » read more

Posted by Gary Finnegan

€228 million for entrepreneurs in Cyprus, €300 million for Dutch SMEs, and €200 million for a train in Spain: The European Investment Bank promised three quarters of a billion Euro in loans to help keep economies moving during the credit crunch – and that was just Friday! The Bank has pledged to make €30 billion… » read more

Posted by Gary Finnegan